Lawrence Karsh, MD

Lawrence Karsh, MD

The Urology Center of Colorado

Denver, CO

Dr. Karsh has practiced Urology in Denver since 1984 and was board Certified in 1986, completing the most recent recertification in 2013. He graduated from the Chicago Medical School and completed his General Surgical training at The University of Colorado Health Sciences Center under Dr. Thomas Starzl. He completed his Urology residency at Brigham and Women’s Hospital/Harvard Medical School under Dr. Ruben Gittes.[su_spacer]

Dr. Karsh is a co-founder of The Urology Center of Colorado where he serves as an attending Urologist and Director of Research. He is a principal investigator with an experience of more than 200 clinical trials. He is a Certified Principal Investigator, certified by the Association of Clinical Research Professionals (ACRP.) Dr. Karsh has authored a number of peer-reviewed publications and serves on the editorial boards for “Urologists in Cancer Care” and “Bladder Cancer.” He is an active member of the AUA, SUO,ASCO, as well as SWOG. He serves on the bladder cancer subcommittee for the SUO Clinical Trials Consortium.[su_spacer]

Dr. Karsh is also a member of the Denver Academy of Surgeons. Dr. Karsh serves as an advisor and consultant to the pharmaceutical industry, participating in drug development and research protocols. He educates physicians across the country about newly approved therapies.

Articles by Lawrence Karsh, MD

Ask the Expert: What Are Some of the Challenges for Urologists Treating Metastatic Castrate Resistant Prostate Cancer Patients?

Lawrence Karsh, MD, The Urology Center of Colorado, Denver, Colorado, discusses what some of the challenges are for urologists treating metastatic castrate resistant prostate cancer patients. Interview produced by Prostatepedia Keywords: metastatic castrate resistant prostate cancer, learning curve, adverse events, therapies, clinical practice...

Read More

The Benefits and Challenges (Present and Future) for the Urologist Treating mCRPC

Dr. Lawrence I. Karsh presented “The Benefits and Challenges (Present and Future) for the Urologist Treating mCRPC” at the 27th annual International Prostate Cancer Update meeting on Friday, January 27, 2017.     Keywords: metastatic castration-resistant prostate cancer, urologists, sipuleucel-t, abiraterone, enzalutamide, denosumab How to cite:  Karsh, Lawrence I.  “The Benefits and Challenges (Present and Future) for the Urologist Treating mCRPC” January 27, 2017. Accessed Dec 2017. https://grandroundsinurology.com/benefits-challenges-present-future-urologist-treating-mcrpc Transcipt The Benefits and Challenges (Present and Future) for the Urologist Treating mCRPC I’m going to talk the benefits and challenges for the urologist treating CRPC. These are my disclosures. So I’m going to try to convince...

Read More

Biosynthesis Inhibitors or Anti-Androgens: Which One Should I Choose?

Dr. Lawrence I. Karsh spoke at the 21st annual Scottsdale Prostate Cancer Symposium 2016 on Saturday, March 12, 2016 on “Biosynthesis Inhibitors or Anti-Androgens: Which One Should I Choose?”.   Keywords: prostate cancer, Abiraterone, Enzalutamide, hormone therapies, CRPC How to cite: Karsh, Lawrence I. “Biosynthesis Inhibitors or Anti-Androgens: Which One Should I Choose?” Grand Rounds in Urology. March 12, 2016. Accessed Dec 2017....

Read More

The Future of Clinical Research in Private Practice: Alive or Dead?

Dr. Karsh presented at the 26th International Prostate Cancer Update on Saturday, January 23, 2016 on “The Future of Clinical Research in Private Practice: Alive or Dead?”.     Keywords: prostrate cancer, development drugs, private practice, regulations How to cite: Karsh, Lawrence I. “The Future of Clinical Research in Private Practice: Alive or Dead?”. Grand Rounds in Urology. January 23, 2016. Dec 2017. https://grandroundsinurology.com/prostate-cancer-lawrence-karsh-future-of-clinical-research-in-private-practice/. Transcript The Future of Clinical Research in Private Practice: Alive or Dead? What I’m going to do is talk about the future of clinical research in private practices. Is it alive or dead? This is the beautiful Taj Majal...

Read More

Join the GRU Community

- Why Join? -